Advisory Committee Review Of Firazyr Canceled

Jerini’s hereditary angiodema candidate has a late April user fee date.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet